Squarepoint
ETON icon

Squarepoint’s Eton Pharmaceutcials ETON Stock Holding History

Squarepoint’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
+59,562
New +$1.75M ﹤0.01% 2286
2026
Q1 		– Sell
-13,482
Closed -$228K – 4445
2025
Q4 		$228K Sell
13,482
-46,163
-77% -$812K ﹤0.01% 3789
2025
Q3 		$1.3M Sell
59,645
-34,151
-36% -$567K ﹤0.01% 2458
2025
Q2 		$1.34M Buy
93,796
+29,001
+45% +$458K ﹤0.01% 2408
2025
Q1 		$841K Buy
+64,795
New +$979K ﹤0.01% 2816
2024
Q3 		– Sell
-41,255
Closed -$136K – 4253
2024
Q2 		$136K Sell
41,255
-7,838
-16% -$27.4K ﹤0.01% 3746
2024
Q1 		$184K Sell
49,093
-14,331
-23% -$62.6K ﹤0.01% 3635
2023
Q4 		$278K Buy
63,424
+18,782
+42% +$75.3K ﹤0.01% 3408
2023
Q3 		$186K Buy
44,642
+30,609
+218% +$118K ﹤0.01% 3433
2023
Q2 		$49K Buy
+14,033
New +$51.6K ﹤0.01% 3442
2020
Q3 		– Sell
-33,126
Closed -$181K – 2572
2020
Q2 		$181K Buy
+33,126
New +$165K ﹤0.01% 1846

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Squarepoint's ETON Position: Q2 2026 in Review

Squarepoint opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 59,562 shares worth $2.16M. The stake represents ﹤0.01% of the portfolio and ranks #2286 among its holdings. This is a return to the name: Squarepoint previously reported a position in ETON as recently as Q4 2025.

Squarepoint first reported a position in ETON in Q2 2020 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Squarepoint held 59,562 shares of Eton Pharmaceutcials worth $2.16M as of Q2 2026.
  • Eton Pharmaceutcials was a new Squarepoint position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2286 holding.
  • Squarepoint first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 11 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.